A phase III trial of APTIOM (eslicarbazepine acetate) for Partial epilepsies in children younger than four years of age.
Phase of Trial: Phase III
Latest Information Update: 15 Mar 2017
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- 15 Mar 2017 New trial record